Full Text View
Tabular View
No Study Results Posted
Related Studies
Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer
This study is currently recruiting participants.
Verified October 2014 by UNC Lineberger Comprehensive Cancer Center
Study NCT01298570   Information provided by UNC Lineberger Comprehensive Cancer Center

First Received on February 16, 2011.   Last Updated on October 6, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial